Pandemic Fraud

A federal class action claims that SCWorx and its CEO Marc S. Schessel falsely claimed that they had sold 2 million “<strong><a href="http://www.courthousenews.com/wp-content/uploads/2020/05/Pandemic-Fraud.pdf">Covid-19 rapid testing kits</a></strong>, ‘with provision for additional weekly orders of 2 million units for 23 weeks, valued at $35M per week,’” goosing its stock price, after which the SEC halted trading in it.</p>

MANHATTAN — A federal class action claims that SCWorx and its CEO falsely claimed that they had sold 2 million “Covid-19 rapid testing kits, ‘with provision for additional weekly orders of 2 million units for 23 weeks, valued at $35M per week,’” goosing its stock price, after which the SEC halted trading in it.

Categories / Health, Securities

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.